Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine for Malaria Prevention in Pregnancy
NCT00811421Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Sep 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised, double-blind trial of mefloquine in malaria (5 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoints: Low birth weight and Peripheral parasitaemia. Started Sep 2009; status: completed.
02
Drugs
mefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00811421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811421.